Table 3.
Pain ≤ 8 (N = 19) | Pain > 8 (N = 27) | p-value | p-value adjusted by Bonferroni method | ||
---|---|---|---|---|---|
Pain VAS score | |||||
Day 6 | − 1.53 ± 0.96 | − 2.74 ± 1.40 | 0.001 | 0.003 | |
Day 13 | − 2.05 ± 1.39 | − 3.48 ± 1.53 | 0.002 | 0.006 | |
Day 36 | − 0.79 ± 1.51 | − 1.82 ± 2.08 | 0.059 | 0.177 | |
FIQ | |||||
Day 6 | − 0.60 ± 10.51 | − 4.53 ± 10.80 | 0.246 | 0.738 | |
Day 13 | − 5.98 ± 13.73 | − 9.65 ± 16.32 | 0.414 | 1.000 | |
Day 36 | 0.41 ± 12.10 | − 4.44 ± 18.31 | 0.284 | 0.852 | |
BPI | |||||
Day 6 | − 7.16 ± 12.92 | − 10.01 ± 19.81 | 0.554 | 1.000 | |
Day 13 | − 16.39 ± 21.31 | − 11.22 ± 15.90 | 0.380 | 1.000 | |
Day 36 | − 8.62 ± 13.53 | − 9.69 ± 24.32 | 0.081 | 0.243 | |
BDI | |||||
Day 6 | − 4.74 ± 9.62 | − 4.52 ± 12.30 | 0.946 | 1.000 | |
Day 13 | − 2.21 ± 18.72 | − 8.52 ± 9.70 | 0.189 | 0.567 | |
Day 36 | − 8.32 ± 11.52 | − 7.19 ± 9.34 | 0.725 | 1.000 | |
BFI | |||||
Day 6 | − 2.47 ± 15.43 | − 15.61 ± 17.50 | 0.003 | 0.009 | |
Day 13 | − 8.26 ± 13.52 | − 10.52 ± 15.82 | 0.612 | 1.000 | |
Day 36 | − 0.68 ± 10.71 | − 7.70 ± 15.91 | 0.081 | 0.243 | |
STAI-I | |||||
Day 6 | 1.37 ± 2.95 | 1.70 ± 7.66 | 0.837 | 1.000 | |
Day 13 | − 0.74 ± 5.15 | − 1.59 ± 9.38 | 0.694 | 1.000 | |
Day 36 | − 3.11 ± 6.25 | − 1.82 ± 11.10 | 0.620 | 1.000 | |
STAI-II | |||||
Day 6 | − 0.42 ± 6.31 | 0.96 ± 7.02 | 0.488 | 1.000 | |
Day 13 | − 1.21 ± 6.39 | − 0.44 ± 8.71 | 0.733 | 1.000 | |
Day 36 | − 1.37 ± 5.94 | 0.85 ± 8.78 | 0.312 | 0.936 | |
MOSS | |||||
Day 6 | − 2.26 ± 7.13 | 2.00 ± 7.46 | 0.057 | 0.171 | |
Day 13 | − 0.95 ± 7.99 | 1.63 ± 6.27 | 0.249 | 0.747 | |
Day 36 | − 2.68 ± 7.31 | 0.41 ± 6.82 | 0.155 | 0.465 |
Values are shown as the mean ± standard deviation.
VAS Visual Analog Scale, FIQ Fibromyalgia Impact Questionnaire, BPI Brief Pain Inventory, BDI Beck Depression Inventory, BFI Brief Fatigue Inventory, STAI State-Trait Anxiety Inventory, MOS-SS Medical Outcomes Study-Sleep Scale.